Valens Semiconductor Ltd. filings document the company’s foreign-issuer current reports, semiconductor connectivity business, governance matters and capital-structure disclosures. Form 6-K reports furnish earnings releases, product announcements involving VA7000 A-PHY chipsets and automotive camera applications, annual meeting voting results, management-transition disclosure, and exhibits incorporated by reference into Form F-3 and Form S-8 registration statements.
The filing record also covers operating and financial results, material-event disclosures, risk factors and corporate governance under the company’s public-company reporting framework. These documents relate to Valens’ audio-video and automotive connectivity markets, including high-speed video and data transmission technologies tied to HDBaseT and MIPI A-PHY.
Valens Company Ltd. submitted a Form 144 notice reporting proposed sales of 15,343 shares in three separate "Distribution In Kind" entries dated 12/08/2022, 03/16/2023, and 05/23/2023. The filing lists shares outstanding of 103,050,266 as of 04/30/2026.
Valens Semiconductor Ltd.’s SVP, R&D Chairman David reported an exercise-and-sell transaction in Ordinary Shares. On April 23, 2026, he exercised stock options for 3,600 shares at $0.86 per share and sold the same 3,600 shares at a weighted average price of $1.6654 per share under a pre-arranged Rule 10b5-1 trading plan. Following these transactions, he holds 403,968 Ordinary Shares directly and retains 87,695 stock options, making this a relatively small, routine disposition compared with his remaining position.
Valens Semiconductor SVP, R&D Chairman David reported an options exercise paired with a small open-market sale of ordinary shares. On April 22, 2026, he exercised stock options for 400 ordinary shares at $0.86 per share and sold 400 shares at $1.65 per share on the same day.
The filing notes these sales were made under a Rule 10b5-1 trading plan adopted on August 16, 2024, indicating they were pre-planned. After the transactions, he directly holds 403,968 ordinary shares and 91,295 stock options, so the net share sale is small relative to his overall position.
Valens Semiconductor insider sale notice: a Form 144 filing lists proposed sales tied to an Employee Stock Option Plan and a recent reported sale by the company's chairman. The Form shows 4,000 ordinary shares associated with an option plan and a reported sale of 8,000 ordinary shares on 04/15/2026 for $11,850.09.
Valens Semiconductor Ltd. director Yaacobi Tal reported a disposition of shares tied to tax withholding. On the vesting of restricted share units, 3,750 Ordinary Shares were withheld and sold by the company at $1.47 per share to satisfy tax withholding obligations. Following this mechanistic transaction, Tal’s direct holdings stand at 73,648 Ordinary Shares.
Valens Semiconductor Ltd. director Moshe Lichtman reported an indirect sale of 3,750 Ordinary Shares at $1.47 per share through NGR Ltd. The shares were withheld and sold by the company to satisfy tax withholding obligations tied to vesting of restricted share units, leaving 126,450 shares indirectly held.
Valens Semiconductor SVP, R&D Chairman David exercised stock options and sold the resulting shares in a pre-planned trade. On April 16, 2026, he sold 2,384 Ordinary Shares at a weighted average price of $1.5049 per share, following the exercise of stock options at $0.86 per share.
The sale was made under a Rule 10b5-1 trading plan adopted on August 16, 2024. After the transactions, he held 403,968 Ordinary Shares directly and had 91,695 stock options remaining, exercisable until June 9, 2031.
VLN submitted a Form 144 notice reporting proposed resale of ordinary shares and listing recent restricted stock unit and sale activity by an insider. The filing lists 8,212 Restricted Stock Units dated 01/15/2026 and two reported sales by Tal Yaacobi: 2,050 shares on 01/20/2026 and 1,400 shares on 03/30/2026.
Valens Semiconductor SVP of R&D Chairman David exercised stock options and sold the resulting shares. He exercised options for 5,616 Ordinary Shares at an exercise price of $0.86 per share, converting a derivative position into common equity.
On the same date, he sold 4,000 Ordinary Shares at $1.4634 per share and 1,616 Ordinary Shares at $1.4906 per share in open-market transactions. The filing notes these sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on August 16, 2024.
After the transactions, he held 403,968 Ordinary Shares directly, indicating he retained a substantial equity stake in Valens Semiconductor Ltd. while monetizing a relatively small portion of his holdings.